DIMENSION(R) CLINICAL CHEMISTRY SYSTEM
Report
- Report Number
- 2517506-2014-00224
- Event Type
- Malfunction
- Date Received
- October 6, 2014
- Date of Event
- May 22, 2014
- Report Date
- September 15, 2014
- Manufacturer
- SIEMENS HEALTHCARE DIAGNOSTICS INC - GLASGOW
- Product Code
- LCP
- PMA / PMN Number
- K102510
- Removal / Correction Number
- 2517506-10-03-2014-008-C
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- KS, US
- Reporter Occupation
- MEDICAL TECHNOLOGIST
Narratives
SIEMENS HEALTHCARE DIAGNOSTICS HAS CONFIRMED THAT THE DIMENSION® (B)(6) FLEX® REAGENT CARTRIDGE LOTS GA4266, BA4273, BA4280, BA4287, GA4301, GA4315, GC4322, GA4343, GA4350, GA4357, GA5013, AND GA5020 EXHIBIT A POSITIVE BIAS AVERAGING 0.4% HEMOGLOBIN A1C UNITS AND OCCASIONALLY UP TO 1.0% (B)(6)UNITS FOR PATIENT SAMPLES WHEN COMPARED TO THE NATIONAL GLYCOHEMOGLOBIN STANDARDIZATION PROGRAM (NGSP). QC SAMPLES MAY EXHIBIT A SIMILAR BIAS. THIS BIAS RESULTED IN COMPLAINTS FOR (B)(6) SURVEY FAILURES. IN THE URGENT MEDICAL DEVICE RECALL LETTER DATED (B)(4) 2014, #14-60 ISSUED TO CUSTOMERS WHO WERE SHIPPED THE IMPACTED LOTS, SIEMENS DIRECTED CUSTOMERS TO DISCONTINUE USE AND TO DISCARD THE IMPACTED LOTS. SIEMENS STATED IT WOULD REPLACE ANY UNUSED INVENTORY OF THE AFFECTED LOTS AT NO CHARGE WITH A NON-AFFECTED LOT.
BIASED (B)(6) RESULTS WERE OBTAINED ON (B)(6) SURVEY SAMPLES. IT IS UNKNOWN IF PATIENT TREATMENT WAS ALTERED OR PRESCRIBED ON THE BASIS OF THE BIASED (B)(6) RESULTS. THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES AS A RESULT OF THE BIASED (B)(6) RESULTS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 624351 | DIMENSION(R) CLINICAL CHEMISTRY SYSTEM | HEMOGLOBIN A1C KIT | LCP | SIEMENS HEALTHCARE DIAGNOSTICS INC - GLASGOW | GA4343 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Disability |